AMPH — Amphastar Pharmaceuticals, Share News
0.000.00%
Last trade - 00:00- $885.83m
- $1.21bn
- $719.89m
Brief: Amphastar Pharmaceuticals Q1 Adjusted Non-GAAP Earnings Per Share $0.27
Amphastar Pharmaceuticals Inc expected to post earnings of 18 cents a share - Earnings Preview
Brief: Amphastar Pharmaceuticals Receives FDA Approval For Morphine Sulfate Injection
Brief: Amphastar Pharmaceuticals Receives FDA Approval For Dextrose Injection
U.S. RESEARCH ROUNDUP- East West Bancorp, Genmark Diagnostics, iHeartMedia
Brief: Amphastar Pharmaceuticals Reports Financial Results For The Three Months And Full-Year Ended December 31, 2020
U.S. STOCKS ON THE MOVE-Amphastar Pharma, Snap, Aprea Therapeutics
U.S. STOCKS ON THE MOVE-Disney, Moleculin, Applied DNA
Amphastar Pharma: Jumps on FDA nod for generic version of hypoglycemia drug
Brief: Amphastar Announces Approval For Glucagon For Injection Kit, 1Mg
Brief: FDA Approves First Generic Of Drug Used To Treat Severe Hypoglycemia
Brief: Amphastar Pharmaceuticals Reports Q3 EPS Of $0.08
U.S. STOCKS ON THE MOVE-Facebook, Amazon.com, Nvidia
U.S. STOCKS ON THE MOVE-Conformis, Oragenics, Himax Technologies, Gamida Cell, Leaf Group
Amphastar Pharma: Gains on FDA nod for atropine sulfate injection
Brief: Amphastar Pharmaceuticals Receives FDA Approval For Atropine Sulfate Injection
Brief: Amphastar Pharmaceuticals Reports Q2 Flat GAAP Earnings
U.S. STOCKS ON THE MOVE-Regeneron, Zoom Video, U.S. oil companies, Apple, U.S. insurers
U.S. STOCKS ON THE MOVE-Kohl's, tanker operators, oil and gas companies, U.S. casinos